LAB — Labiana Health SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSuper Stock

Annual income statement for Labiana Health SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	57.8	57	57.8	58.5	66.3
Cost of Revenue
Gross Profit	34.1	35.4	32.5	34.7	41.4
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	55.4	56.4	64.1	60.5	61.4
Operating Profit	2.46	0.54	-6.23	-2.06	4.86
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.541	-2.12	-7.84	-5.27	-0.03
Provision for Income Taxes
Net Income After Taxes	1.07	-2.11	-9.11	-4.49	0.207
Minority Interest
Net Income Before Extraordinary Items
Net Income	1.07	-1.78	-8.94	-4.42	0.253
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1.07	-1.78	-8.94	-4.42	0.253
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.162	-0.182	-0.875	-0.583	0.103